ClinicalTrials.Veeva

Menu

Investigation of the Psychosocial Factors Responsible for the Late Recourse to HIV Testing Within MSM (ReTarD)

F

French National Agency for Research on AIDS and Viral Hepatitis

Status

Unknown

Conditions

AIDS
HIV Seropositivity

Treatments

Behavioral: Focus group
Behavioral: self questionnaire
Behavioral: online self questionnaire
Behavioral: Individual interview

Study type

Observational

Funder types

Other

Identifiers

NCT03661203
ANRS ReTarD VIH
2018-A00825-50 (Other Identifier)

Details and patient eligibility

About

The present study will try to investigate and analyze the psycho-social hindrances and levers concerning the recourse to late HIV testing among the MSM population.

This study is divided in two parts. The first one will consist of individual and groups interviews. Then, depending on the items that will rise from the first part of the study, groups interview will take place based on theses items. Finally, a questionnaire build from the collected information will be sent to MSM community in order to obtain quantitative results.

Full description

The late recourse to HIV testing, among the population in general way and among MSM population in a more specific way, participates in the dissemination of the HIV epidemic. Actually, there is no cure for HIV infection, but treatments that reduce viral charge to undetectable level exists. When diagnosed and treated earlier, seropositive people will be less communicating the virus because of the reduction of their viral charge.

This study aims to uncover the reasons behind the late recourse to HIV testing in MSM population facing a high risk of contamination.

The study hypothesis, is that late recourse to HIV testing is probably related to social and economics factors like age, social standing, accessibility to the diagnosis or even to a traditional beliefs or a fear of stigma etc. To shed the light on these factors, the main objectives of the investigator will try to investigate and analyze the psycho-social hindrances and levers through a quantitative and qualitative approach. This plurality of approaches is a part of a methodological triangulation method described by Kalampalikis & Apostolidis, 2016.

People among MSM community having had a late or very late HIV test (as defined by biological parameters :CD4≤200/mm3 or having been diagnosed with AIDS), will be recruited in this study. During the first phase of the study, the eligible population will participate to individual or group interview . This qualitative part of the project will allow the set up of a questionnaire that will be diffused widely to the MSM community to have quantitative results.

Enrollment

1,190 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • HIV-positive
  • Self-reported homo-or bisexual contamination mode
  • TCD4 + / mm3 200 200 lymphocyte count or Have an AIDS classifying event
  • Diagnosis of HIV positive for at least two months and for a maximum of 24 months

Exclusion criteria

  • Primary infection

Trial design

1,190 participants in 2 patient groups

Qualitative cohort
Description:
The cohort consists of MSM with late HIV diagnosis. The person from this cohort will participate to round table called also focus group or individual interview.
Treatment:
Behavioral: Focus group
Behavioral: self questionnaire
Behavioral: Individual interview
Quantitative cohort
Description:
MSM community will be invited to participate to an online self questionnaire established from the information gathered from the previous cohort.
Treatment:
Behavioral: online self questionnaire

Trial contacts and locations

4

Loading...

Central trial contact

Marie Préau, PR

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems